Effect of carvedilol on neuronal survival and poly(ADP-ribose) polymerase activity in hippocampus after transient forebrain ischemia

Acta Neurobiologiae Experimentalis

Volumn 65, Issue 2, 2005, Pages 137-143

  Strosznajder, Robert P ^a   Jesko, Henryk ^a   Dziewulska, Jolanta ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Carvedilol; Ischemia; Neuroprotection; PARP; Reperfusion

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GERBIL; HIPPOCAMPUS; MALE; NERVE CELL; NONHUMAN; REPERFUSION; TRANSIENT ISCHEMIC ATTACK;

ADRENERGIC BETA-ANTAGONISTS; ANALYSIS OF VARIANCE; ANIMALS; CARBAZOLES; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GERBILLINAE; HIPPOCAMPUS; ISCHEMIC ATTACK, TRANSIENT; MALE; NAD; NEURONS; POLY(ADP-RIBOSE) POLYMERASES; PROPANOLAMINES; REPERFUSION INJURY; TIME FACTORS;

EID: 21044454642     PISSN: 00651400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Beneke S, Diefenbach J, Burkle A (2004) Poly(ADP-ribosyl)ation inhibitors: promising drug candidates for a wide variety of pathophysiologic conditions. Int J Cancer 111: 813-818.
2. Book WM (2002) Carvedilol: A nonselective beta blocking agent with antioxidant properties. Congest Heart Fail 8: 173-177, 190.
3. Chalimoniuk M, Strosznajder J (1998) NMDA receptor-dependent nitric oxide and cGMP synthesis in brain hemispheres and cerebellum during reperfusion after transient forebrain ischemia in gerbils: Effect of 7-nitroindazole. J Neurosci Res 54: 681-690.
4. Chan PH (2004) Mitochondria and neuronal death/survival signaling pathways in cerebral ischemia. Neurochem Res 29: 1943-1949.
5. Chen J, Jin K, Chen M, Pei W, Kawaguchi K, Greenberg DA, Simon RP (1997) Early detection of DNA strand breaks in the brain after transient focal ischemia: Implications for the role of DNA damage in apoptosis and neuronal cell death. J Neurochem 69: 232-245.
6. Chiarugi A (2002) Poly(ADP-ribose) polymerase: killer or conspirator? The 'suicide hypothesis' revisited. Trends Pharmacol Sci 23: 122-129.
7. Cookson MR, Ince PG, Shaw PJ (1998) Peroxynitrite and hydrogen peroxide induced cell death in the NSC34 neuroblastoma x spinal cord cell line: Role of poly (ADP-ribose) polymerase. J Neurochem 70: 501-508.
8. Endres M, Wang Z, Namura S, Waeber C, Moskowitz MA (1997) Ischemic brain injury is mediated by the activation of poly(ADP-ribose) polymerase. J Cereb Blood Flow Metab 17: 1143-1151.
9. Gao F, Chen J, Lopez BL, Christopher TA, Gu J, Lysko P, Ruffolo RR Jr, Ohlstein EH, Ma XL, Yue TL (2000) Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model. Eur J Pharmacol 406: 109-116.
10. Habon T, Szabados E, Kesmarky G, Halmosi R, Past T, Sumegi B, Toth K (2001) The effect of carvedilol on enhanced ADP-ribosylation and red blood cell membrane damage caused by free radicals. Cardiovasc Res 52: 153-160.
11. Lautier D, Hoflack JC, Kirkland JB, Poirier D, Poirier GG (1994) The role of poly(ADP-ribose) metabolism in response to active oxygen cytotoxicity. Biochim Biophys Acta 1221: 215-220.
12. Lipton P (1999) Ischemic cell death in brain neurons. Physiol Rev 79: 1431-1568.
13. Lysko PG, Lysko KA, Yue T-L, Webb CL, Gu J-L, Feuerstein G (1992) Neuroprotective effects of carvedilol, a new antiphypertensive agent, in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke 23: 1630-1635.
14. Lysko PG, Webb CL, Feuerstein G (1994) Neuroprotective effects of carvedilol, a new antihypertensive, as a Na+ channel modulator and glutamate transport inhibitor. Neurosci Lett 171: 77-80.
15. Nakamura K, Kusano K, Nakamura Y, Kakishita M, Ohta K, Nagase S, Yamamoto M, Miyaji K, Saito H, Monta H, Emori T, Matsubara H, Toyokuni S, Ohe T (2002) Carvedilol decreases elevated oxidative stress in human failing myocardium. Circulation 105: 2867-2871.
16. Nisselbaum JS, Green S (1969) A simple ultramicro method for determination of pyridine nucleotides in tissues. Anal Biochem 27: 212-217.
17. Savitz SI, Erhardt JA, Anthony JV, Gupta G, Li X, Barone FC, Rosenbaum DM (2000) The novel β-blocker, carvedilol, provides neuroprotection in transient focal stroke. J Cereb Blood Flow Metab 20: 1197-1204.
18. Shah GM, Poirier D, Desnoyers S, Saint-Martin S, Hoflack JC, Rong P, ApSimon M, Kirkland JB, Poirier GG (1996) Complete inhibition of poly(ADP-ribose) polymerase activity prevents the recovery of C3H10T1/2 cells from oxidative stress. Biochim Biophys Acta 1312: 1-7.
19. Singh D, Chander V, Chopra K (2004) Carvedilol attenuates ischemia-reperfusion-induced oxidative renal injury in rats. Fundam Clin Pharmacol 18: 627-634.
20. Skaper SD (2003) Poly(ADP-Ribose) polymerase-1 in acute neuronal death and inflammation: A strategy for neuroprotection. Ann N Y Acad Sci 993: 217-228.
21. Stern N, Hochman A, Zemach N, Weizman N, Hammel I, Shiloh Y, Rotman G, Barzilai A (2002) Accumulation of DNA damage and reduced levels of nicotine adenine dinucleotide in the brains of Atm-deficient mice. J Biol Chem 277: 602-608.
22. Strosznajder J, Chalimoniuk M (1996) Biphasic enhancement of nitric oxide synthase activity and cGMP level following brain ischemia in gerbils. Acta Neurobiol Exp (Wars) 56: 71-81.
23. Strosznajder RP, Gadamski R, Czapski GA, Jesko H, Strosznajder JB (2003) Poly(ADP-ribose) polymerase during reperfusion after transient forebrain ischemia: Its role in brain edema and cell death. J Mol Neurosci 20: 61-72.
24. Strosznajder RP, Jesko H, Zambrzycka A (2005) Poly(ADP-ribose) Polymerase the nuclear target in signal transduction and Its role in brain ischemia-reperfusion injury. Mol Neurobiol 31 (in press).
25. Szabo C, Dawson VL (1998) Role of poly(ADP-ribose) synthase in inflammation and ischemia-reperfusion. Trends Pharmacol Sci 19: 287-298.
26. Thiemmermann C, Bowes J, Myint FP, Vane JR (1997) Inhibition of the activity of poly(ADP-ribose) synthase reduces ischemia-reperfusion injury in the heart and skeletal muscle. Proc Natl Acad Sci U S A 94: 679-683.
27. Ying W, Alano CC, Gamier P, Swanson RA (2005) NAD+ as a metabolic link between DNA damage and cell death. J Neurosci Res 79: 216-223.
28. Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, Poirier GG, Dawson TM, Dawson VL. (2002) Mediation of poly(ADP-ribose) polymerase-1- dependent cell death by apoptosis-inducing factor. Science 297: 259-263.
29. Yue TL, Lysko PG, Barone FC, Gu JL, Ruffolo RR Jr, Feuerstein GZ (1994) Carvedilol, a new antihypertensive drug with unique antioxidant activity: Potential role in cerebroprotection. Ann N Y Acad Sci 738: 230-242.
30. Zingarelli B, Cuzzocrea S, Zsengeller Z, Salzman AL, Szabo C (1997) Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly(ADP-ribose) synthetase. Cardiovascular Res 36: 205-215.
31. Zhang J, Pieper A, Snyder SH (1995) Poly(ADP-ribose) synthetase activation: An early indicator of neurotoxic DNA damage. J Neurochem 65: 1411-1414.